Emerging nanoparticle designs against bacterial infections.
Zhidong ZhouMingxuan KaiShuyan WangDan WangYifei PengYiyan YuWeiwei GaoLiangfang ZhangPublished in: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology (2023)
The rise of antibiotic resistance has caused the prevention and treatment of bacterial infections to be less effective. Therefore, researchers turn to nanomedicine for novel and effective antibacterial therapeutics. The effort resulted in the first-generation antibacterial nanoparticles featuring the ability to improve drug tolerability, circulation half-life, and efficacy. Toward developing the next-generation antibacterial nanoparticles, researchers have integrated design elements that emphasize physical, broad-spectrum, biomimetic, and antivirulence mechanisms. This review highlights four emerging antibacterial nanoparticle designs: inorganic antibacterial nanoparticles, responsive antibacterial nanocarriers, virulence nanoscavengers, and antivirulence nanovaccines. Examples in each design category are selected and reviewed, and their structure-function relationships are discussed. These emerging designs open the door to nontraditional antibacterial nanomedicines that rely on mechano-bactericidal, function-driven, nature-inspired, or virulence-targeting mechanisms to overcome antibiotic resistance for more effective antibacterial therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
Keyphrases
- silver nanoparticles
- cancer therapy
- essential oil
- escherichia coli
- drug discovery
- anti inflammatory
- pseudomonas aeruginosa
- staphylococcus aureus
- drug delivery
- stem cells
- physical activity
- emergency department
- randomized controlled trial
- small molecule
- open label
- cystic fibrosis
- sensitive detection
- clinical trial
- smoking cessation
- quantum dots
- finite element analysis
- placebo controlled
- living cells